CNTN6

Chr 3

contactin 6

Also known as: NB3

The protein is a GPI-anchored neuronal membrane glycoprotein that mediates cell surface interactions during nervous system development and participates in oligodendrocyte generation by acting as a NOTCH1 ligand. Mutations cause autosomal recessive developmental and epileptic encephalopathy with movement abnormalities, typically presenting in infancy with seizures, developmental delay, and motor coordination problems. This gene has a GeneReviews entry, indicating established clinical significance in pediatric neurology.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.15
Clinical SummaryCNTN6
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDisputed

Disputed — evidence questions this relationship

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 81 VUS of 100 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.15LOEUF
pLI 0.000
Z-score 0.62
OE 0.91 (0.721.15)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-3.00Z-score
OE missense 1.36 (1.281.45)
735 obs / 538.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.91 (0.721.15)
00.351.4
Missense OE1.36 (1.281.45)
00.61.4
Synonymous OE1.33
01.21.6
LoF obs/exp: 49 / 53.9Missense obs/exp: 735 / 538.7Syn Z: -3.62
DN
0.6745th %ile
GOF
0.6443th %ile
LOF
0.4135th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS81
Likely Benign3
2
Pathogenic
81
VUS
3
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
2
0
2
Likely Pathogenic
0
0
0
0
0
VUS
2
70
9
0
81
Likely Benign
0
2
1
0
3
Benign
0
0
0
0
0
Total27212086

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CNTN6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →